COMPANY
PFIZER
PFIZER: trial sponsor, recalling firm for Carfilzomib, Colistin, Ciclosporin, Degarelix, Goserelin, Leuprolide, Liraglutide, Semaglutide, Tirzepatide, Triptorelin, Vancomycin, Daptomycin, as stated by public registers.
Also written as: Pfizer.
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Carfilzomib | 4 registered trials Trial register ClinicalTrials.gov |
|---|---|
| Colistin | 1 registered trial Trial register ClinicalTrials.gov |
| Ciclosporin | 1 registered trial Trial register ClinicalTrials.gov |
| Degarelix | 1 registered trial Trial register ClinicalTrials.gov |
| Goserelin | 1 registered trial Trial register ClinicalTrials.gov |
| Leuprolide | 2 registered trials Trial register ClinicalTrials.gov |
| Liraglutide | 1 registered trial Trial register ClinicalTrials.gov |
| Semaglutide | 2 registered trials Trial register ClinicalTrials.gov |
| Tirzepatide | 1 registered trial Trial register ClinicalTrials.gov |
| Triptorelin | 1 registered trial Trial register ClinicalTrials.gov |
| Vancomycin | 14 registered trials Trial register ClinicalTrials.gov |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Daptomycin | Class II recall, Terminated, 2018-08-08 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.